ArisGlobal, a leading life sciences technology company and creator of LifeSphere®, today announced three new cutting-edge product offerings that will advance pharmacovigilance and regulatory ...

New Delhi, has established a dedicated committee to monitor and report adverse events related to drugs and medical devices ...

The webinar will explore how AI can transform pharmacovigilance by enhancing efficiency, reducing errors, and addressing ...

The local subsidiary of German firm Glenwood GmbH has opened a facility in Taguig City to help pharmaceutical companies ensure drug safety, manage risks and comply with global standards.

The Drug Safety Research Unit (DSRU) has announced the appointment of Linda Härmark as its new director.

Whilst job applications have evolved over the years to bring you new ways of showcasing your skills and experiences, what’s ...

AN 18-year-old in India has made history by securing the Guinness world record for the hairiest male face. Lalit Patidar has ...

Regulatory Shifts and Data-Sharing Advancements Fuel Global Pharmacovigilance Growth, Opening Doors for Seamless Compliance ...

The US pharmacovigilance market is expanding due to rising chronic diseases, stringent FDA regulations, and AI-driven ...

Glenwood Services Philippines Inc. (GSPI) registered with the Board of Investments (BOI) to launch the first pharmaceutical ...

The Pharmacovigilance Programme of India (“PvPI”) is the primary, drug safety monitoring programme in India which collects, collates and analyses drug-related adverse events received through various ...

The FDA Adverse Event Reporting System (FAERS) is one of the largest global repositories of pharmacovigilance data, encompassing AE reports from diverse sources, including physicians, pharmacists, ...